Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

NCT04385836 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

150

Enrollment

OTHER_GOV

Sponsor class

Conditions

Coronavirus

Interventions

DRUG: alpha one antitrypsin inhalation

Sponsor

Ministry of Health, Saudi Arabia